These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21371858)

  • 1. Origins of platelet transfusion therapy.
    Freireich EJ
    Transfus Med Rev; 2011 Jul; 25(3):252-6. PubMed ID: 21371858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood platelet kinetics and platelet transfusion.
    Aster RH
    J Clin Invest; 2013 Nov; 123(11):4564-5. PubMed ID: 24177466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods.
    Apelseth TO; Bruserud O; Wentzel-Larsen T; Hervig T
    Transfusion; 2010 Apr; 50(4):766-75. PubMed ID: 20030789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a freshly prepared thrombocyte mass in thrombocytopenic hemorrhages].
    Baĭdurin SA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):33-9. PubMed ID: 7367409
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet transfusion: future directions.
    Slichter SJ
    Vox Sang; 2004 Jul; 87 Suppl 2():47-51. PubMed ID: 15209878
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice.
    Harrison P; Segal H; Briggs C; Murphy M; Machin S
    Cytometry B Clin Cytom; 2005 Sep; 67(1):1-5. PubMed ID: 15918161
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
    Diedrich B; Ringdén O; Watz E; Shanwell A
    Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
    de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
    BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet transfusions.
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1979 Nov; 121(10):1353-8. PubMed ID: 391376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyophilized platelets: fifty years in the making.
    Bode AP; Fischer TH
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):125-33. PubMed ID: 17364477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
    Apelseth TO; Hervig T; Bruserud O
    Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of infusion methods on platelet count, morphology, and corrected count increment in children with cancer: in vitro and in vivo studies.
    Norville R; Hinds P; Wilimas J; Fairclough D; Fischl S; Kunkel K
    Oncol Nurs Forum; 1994; 21(10):1669-73. PubMed ID: 7854929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of infusion rate on platelet outcomes and patient responses in children with cancer: an in vitro and in vivo study.
    Norville R; Hinds P; Wilimas J; Fischl S; Kunkel K; Fairclough D
    Oncol Nurs Forum; 1997; 24(10):1789-93. PubMed ID: 9399276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
    Kerkhoffs JL; van Putten WL; Novotny VM; Te Boekhorst PA; Schipperus MR; Zwaginga JJ; van Pampus LC; de Greef GE; Luten M; Huijgens PC; Brand A; van Rhenen DJ;
    Br J Haematol; 2010 Jul; 150(2):209-17. PubMed ID: 20507310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.